Skip to main content

Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes.

Nature medicine2025-04-09PubMed
Total: 81.5Innovation: 8Impact: 8Rigor: 8Citation: 9

Summary

In two Swedish cohorts, >500 metabolites associated with impaired glucose control were identified, about one-third linked to altered gut microbiota. Microbiome-associated metabolites were modulated by short-term lifestyle changes (diet/exercise), highlighting a modifiable microbiome–metabolome axis influencing glycemic homeostasis.

Key Findings

  • Identified >500 circulating metabolites associated with impaired glucose control in two cohorts (n=1,167).
  • Approximately one-third of these metabolites were linked to gut microbiome alterations.
  • Short-term lifestyle changes modulated microbiome-associated metabolites in a lifestyle-specific manner.

Clinical Implications

Supports integrating microbiome–metabolome profiling to stratify T2D risk and tailor diet/exercise interventions, potentially improving adherence and glycemic outcomes via personalized targets.

Why It Matters

Provides high-resolution, human evidence that microbiome-associated metabolites mediate impaired glucose control and respond to lifestyle, enabling precision nutrition/behavioral strategies in T2D.

Limitations

  • Observational design limits causal inference despite robust associations
  • Generalizability beyond European ancestry cohorts requires validation

Future Directions

Interventional trials targeting microbiome–metabolome nodes; mechanistic studies of key microbe–metabolite pairs (e.g., hippurate pathways) and precision lifestyle prescriptions.

Study Information

Study Type
Cohort (prospective observational with metabolomics)
Research Domain
Pathophysiology/Diagnosis/Prevention
Evidence Level
II - Prospective observational cohort evidence linking metabolites, microbiome, and glycemic control
Study Design
OTHER